Stay updated on Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov site footer displays an updated software revision number.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe ClinicalTrials.gov site revision identifier in the footer changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check29 days agoChange DetectedA site-wide NIH banner announces a website transition and says the agency is adopting “Super Intelligence” terminology in place of “Artificial Intelligence.”SummaryDifference0.8%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record content appears unchanged.SummaryDifference0.1%

- Check43 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.7.0 is added to the record history and an older revision v3.6.6 is removed, updating the page to reflect the latest version history.SummaryDifference0.1%

Stay in the know with updates to Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.